Showing 1 - 10 results of 10 for search 'Joseph T Barbieri', query time: 0.04s Refine Results
  1. 1
    Vaccines against Botulism

    Vaccines against Botulism by Grace Sundeen, Joseph T. Barbieri

    Published 2017-09-01
    Get full text
    Article
  2. 2
    Light Chain Diversity among the Botulinum Neurotoxins

    Light Chain Diversity among the Botulinum Neurotoxins by Alexander P. Gardner, Joseph T. Barbieri

    Published 2018-07-01
    Get full text
    Article
  3. 3
    Tetanus Toxin <italic toggle="yes">cis</italic>-Loop Contributes to Light-Chain Translocation

    Tetanus Toxin <italic toggle="yes">cis</italic>-Loop Contributes to Light-Chain Translocation by Madison Zuverink, Matthew Bluma, Joseph T. Barbieri

    Published 2020-06-01
    Get full text
    Article
  4. 4
    How Botulinum Neurotoxin Light Chain A1 Maintains Stable Association with the Intracellular Neuronal Plasma Membrane

    How Botulinum Neurotoxin Light Chain A1 Maintains Stable Association with the Intracellular Neuronal Plasma Membrane by Alexander P. Gardner, Joseph T. Barbieri, Sabine Pellett

    Published 2022-11-01
    Get full text
    Article
  5. 5
    Resolution of Two Steps in Botulinum Neurotoxin Serotype A1 Light Chain Localization to the Intracellular Plasma Membrane

    Resolution of Two Steps in Botulinum Neurotoxin Serotype A1 Light Chain Localization to the Intracellular Plasma Membrane by Alexander Gardner, William H. Tepp, Marite Bradshaw, Joseph T. Barbieri, Sabine Pellett

    Published 2021-10-01
    Get full text
    Article
  6. 6
    A Novel High-Potency Tetanus Vaccine

    A Novel High-Potency Tetanus Vaccine by Amanda Przedpelski, William H. Tepp, Sabine Pellett, Eric A. Johnson, Joseph T. Barbieri

    Published 2020-08-01
    Get full text
    Article
  7. 7
    Botulinum Neurotoxin A4 Has a 1000-Fold Reduced Potency Due to Three Single Amino Acid Alterations in the Protein Receptor Binding Domain

    Botulinum Neurotoxin A4 Has a 1000-Fold Reduced Potency Due to Three Single Amino Acid Alterations in the Protein Receptor Binding Domain by William H. Tepp, Marite Bradshaw, Alexander P. Gardner, Rebecca L. Kaufman, Joseph T. Barbieri, Sabine Pellett

    Published 2023-03-01
    Get full text
    Article
  8. 8
    Pseudomonas aeruginosa utilizes the type III secreted toxin ExoS to avoid acidified compartments within epithelial cells.

    Pseudomonas aeruginosa utilizes the type III secreted toxin ExoS to avoid acidified compartments within epithelial cells. by Susan R Heimer, David J Evans, Michael E Stern, Joseph T Barbieri, Timothy Yahr, Suzanne M J Fleiszig

    Published 2013-01-01
    Get full text
    Article
  9. 9
    The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes

    The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes by Sabine Pellett, Marite Bradshaw, William H. Tepp, Christina L. Pier, Regina C. M. Whitemarsh, Chen Chen, Joseph T. Barbieri, Eric A. Johnson

    Published 2018-05-01
    Get full text
    Article
  10. 10
    Testing a Recombinant Form of Tetanus Toxoid as a Carrier Protein for Glycoconjugate Vaccines

    Testing a Recombinant Form of Tetanus Toxoid as a Carrier Protein for Glycoconjugate Vaccines by Davide Oldrini, Roberta Di Benedetto, Martina Carducci, Daniele De Simone, Luisa Massai, Renzo Alfini, Barbara Galli, Brunella Brunelli, Amanda Przedpelski, Joseph T. Barbieri, Omar Rossi, Carlo Giannelli, Rino Rappuoli, Francesco Berti, Francesca Micoli

    Published 2023-11-01
    Get full text
    Article

Search Tools: